Section 1. Report Objective, and Methodology
- Scope of Research
- Research Methodology
- Assumptions
- Research Sources
- Primary Research
- Secondary Research
- Paid Databases
Section 2. Report Summary
- Global Market Snapshot, 2022-2030
- Executive Summary by Segments
- Market Overview, By Treatment Type
- Market Overview, By Therapy Area
- Market Overview, By Route of Administration
- Market Overview, By Distribution Channel
- Market Overview, By Region
Section 3. Key Insights
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Developments
- Leading Brands
- Price Trend Analysis
- Pipeline Analysis
- Porter’s Analysis
- Epidemiology
- Technology Insights
- Impact of COVID-19
Section 4. Global Monoclonal Antibodies Market, By Treatment Type, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Treatment Type
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Biologics (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Biosimilars (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 5. Global Monoclonal Antibodies Market, By Therapy Area, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Therapy Area
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Oncology (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Neurological Diseases (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Cardiovascular Diseases (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Infectious Diseases (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Musculoskeletal Diseases (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Hematologic Diseases (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 6. Global Monoclonal Antibodies Market, By Route of Administration, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Therapy Area
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Oral (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Injectable (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 7. Global Monoclonal Antibodies Market By Distribution Channel, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Hospital Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Specialty Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Online Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 8. Global Monoclonal Antibodies Market By Region, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- North America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Therapy Area (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Route of Administration (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- U.S.
- Canada
- Latin America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Therapy Area (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Route of Administration (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Brazil
- Mexico
- Rest of Latin America
- Europe
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Therapy Area (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Route of Administration (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Therapy Area (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Route of Administration (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- China
- Japan
- South Korea
- India
- ASEAN
- Rest of APAC
- Middle East and Africa
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Therapy Area (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Route of Administration (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Saudi Arabia
- UAE
- Rest of MEA
Section 9. Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Pfizer, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- PTC Therapeutics
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- AstraZeneca
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Novartis AG
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Takeda Pharmaceutical Company
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Bayer AG
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- AbbVie Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Merck & Co. Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Bristol Myers Squibb
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
Frequently Asked Questions
The current market size of the monoclonal antibodies industry is US$ 210.06 billion in 2023.
Rising prevalence of chronic diseases, high demand for biologics, and increasing R&D activities in genomics are contributing significantly to the growth of the Monoclonal Antibodies market.
High cost of monoclonal antibody therapies and limited access to care in developing countries are the key factors hampering the growth of the Monoclonal Antibodies Market.
The leading component segment in the Monoclonal Antibodies Market is human monoclonal antibodies.
Roche, AbbVie, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Eli Lilly, Merck are some of the major players operating in the Monoclonal Antibodies Market.
The monoclonal antibodies market is expected to grow at a compound annual growth rate (CAGR) of 11.6% from 2023 to 2030, reaching a market size of US$ 359.2 billion by 2030.